A. Hirano

发表

Allelic Losses of Loci at 3 p 25 . 1 , 8 p 22 , 13 q 12 , 17 p 13 . 3 , and 22 q 13 Correlate with Postoperative Recurrence in Breast Cancer 1

Yusuke Nakamura, M. Emi, F. Akiyama, 2001 .

Allelic losses as prognostic markers for breast cancers

Y. Nakamura, M. Emi, S. Haga, 2001, International Journal of Clinical Oncology.

Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer.

Y. Nakamura, M. Emi, F. Akiyama, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Long‐term effect of exemestane therapy on bone mineral density supported by bisphosphonates: Results of 5‐year adjuvant treatment in postmenopausal women with early‐stage breast cancer

Tadao Shimizu, K. Ogura, A. Hirano, 2018, Asia-Pacific journal of clinical oncology.

The effect of anastrozole on bone mineral density during the first 5 years of adjuvant treatment in postmenopausal women with early breast cancer

Tadao Shimizu, J. Kinoshita, K. Ogura, 2015, SpringerPlus.

Association of allelic loss at 8p22 with poor prognosis among breast cancer cases treated with high-dose adjuvant chemotherapy.

Yusuke Nakamura, M. Emi, F. Akiyama, 2002, Cancer letters.

Down-regulation in human cancers of DRHC, a novel helicase-like gene from 17q25.1 that inhibits cell growth.

M. Emi, T. Yokota, I. Mikami, 2003, Cancer letters.

Monotherapy with paclitaxel as third-line chemotherapy against anthracycline-pretreated and docetaxel-refractory metastatic breast cancer

S. Haga, O. Watanabe, Tadao Shimizu, 2002, Breast cancer.

A Study on Skin-Sparing Mastectomy in Patients Ineligible for Breast-Conserving Therapy

O. Watanabe, Tadao Shimizu, J. Kinoshita, 2009 .

Two novel single-nucleotide polymorphisms of the Caspase-9 (CASP9) gene in the Japanese population

M. Emi, T. Kajiwara, H. Harada, 2001, Genes and Immunity.

Expression of a CD44 variant and VEGF-C and the implications for lymphatic metastasis and long-term prognosis of human breast cancer.

O. Watanabe, Tadao Shimizu, H. Imamura, 2005, Journal of experimental & clinical cancer research : CR.

Ann. Cancer Res. Ther. Vol. 23, No. 1, pp. 9-13, 2015

Tadao Shimizu, J. Kinoshita, K. Ogura, 2015 .

Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers

Yusuke Nakamura, M. Emi, F. Akiyama, 1997, Breast cancer.

Expression of twist and wnt in human breast cancer.

O. Watanabe, Tadao Shimizu, H. Imamura, 2004, Anticancer research.

Expression profiling to predict postoperative prognosis for estrogen receptor‐negative breast cancers by analysis of 25,344 genes on a cDNA microarray

Tatsuhiko Tsunoda, Yoshio Miki, Fujio Kasumi, 2004, Cancer science.

Maximum density of tumor staining obtained by preoperative IV-DSA as a prognostic indicator for node-negative breast cancer

S. Haga, O. Watanabe, Tadao Shimizu, 1999, Breast cancer.

Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study)

M. Okada, N. Masuda, S. Ohno, 2021, Breast Cancer.

Outcome of Primary Endocrine Therapy in Postmenopausal Patients with Endocrine-responsive Breast Cancer

O. Watanabe, Tadao Shimizu, J. Kinoshita, 2009 .

Expression of cyclooxygenase-2 in malignant and benign breast tumors.

O. Watanabe, Tadao Shimizu, H. Imamura, 2003, Anticancer research.

A Comparison of Indocyanine Green Fluorescence Imaging Plus Blue Dye and Blue Dye Alone for Sentinel Node Navigation Surgery in Breast Cancer Patients

Tadao Shimizu, J. Kinoshita, M. Fujibayashi, 2012, Annals of Surgical Oncology.

Nine novel single-nucleotide polymorphisms in the integrin β4 (ITGB4) gene in the Japanese population

M. Emi, T. Kajiwara, H. Harada, 2001, Journal of Human Genetics.

Epirubicin and cyclophosphamide followed by docetaxel as primary systemic chemotherapy in locally advanced breast cancer.

O. Watanabe, Tadao Shimizu, J. Kinoshita, 2008, Anticancer research.

A phase II study of epirubicin and cyclophosphamide followed by weekly paclitaxel with or without trastuzumab as primary systemic therapy in locally advanced breast cancer.

O. Watanabe, Tadao Shimizu, J. Kinoshita, 2010, Anticancer research.

Breast-conserving surgery without radiation in elderly women with early breast cancer.

Tadao Shimizu, K. Ogura, A. Hirano, 2019, Surgical oncology.

A Case of Obstructive Jaundice Due to Hepatic and Hepatoportal Lymph Node Metastases of Breast Cancer

Tadao Shimizu, S. Shiozawa, K. Ogura, 2010 .

IV‐DSA is a new diagnostic tool for axillary lymph node metastasis in breast cancer patients

O. Watanabe, Tadao Shimizu, H. Imamura, 2004, Journal of Surgical Oncology.

Effect of adjuvant chemotherapy in patients with ER + /HER2− breast cancer, assessed by propensity score matching: significance of nuclear grade and nodal status

Tadao Shimizu, K. Ogura, A. Hirano, 2020, Breast Cancer.

A Case of an Early Invasive Sigmoid Colon Cancer Resulted to Metastasize to the Breast

Tadao Shimizu, K. Ogura, A. Hirano, 2014 .

Successful neoadjuvant therapy with trastuzumab, paclitaxel and epirubicin for an elderly patient with inflammatory breast cancer.

O. Watanabe, Tadao Shimizu, J. Kinoshita, 2010, Anticancer research.

The combination of epirubicin plus docetaxel as neoadjuvant chemotherapy in locally-advanced breast cancer.

O. Watanabe, Tadao Shimizu, H. Imamura, 2006, Anticancer research.

Epirubicin/Cyclophosphamide followed by Docetaxel as Primary Systemic Therapy in Breast Cancer

Tadao Shimizu, J. Kinoshita, M. Fujibayashi, 2014 .

S-1-associated hand-foot syndrome as a prognostic factor in patients with metastatic breast cancer

Tadao Shimizu, J. Kinoshita, K. Ogura, 2015 .

[HER2-Positive Breast Cancer with Severe Infusion Reaction to Pertuzumab plus Trastuzumab-A Case Report].

K. Ogura, A. Hirano, H. Inoue, 2018, Gan to kagaku ryoho. Cancer & chemotherapy.

Experience of intravenous digital subtraction angiography (IV-DSA) in evaluation of neoadjuvant chemotherapy for advanced breast cancer

S. Haga, O. Watanabe, H. Imamura, 2002, International Journal of Clinical Oncology.